← brief for 2026-08-19 · Slowing decline

Risk of nephrolithiasis with finerenone versus other chronic kidney disease medications: a comparative real-world evidence study

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This real-world study of 15,000 patients compares the risk of kidney stones with finerenone versus other common kidney drugs. Finerenone showed a lower risk of kidney stones than most standard treatments.

Who did this work

Yihong Chen (National Cheng Kung University) · Tung-Liang Hwang (National Cheng Kung University Hospital) · Ze‐Hong Lu (National Cheng Kung University Hospital) · Chan-Jung Liu (National Cheng Kung University Hospital)

Source

Paper · OpenAlex, CKD works · 2026-08-18
https://doi.org/10.1038/s41598-026-65475-8